FDA Drug Application (009296) for SERPASIL-APRESOLINE by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number009296
Product Number002
FormTABLET;ORAL
Dosage50MG;0.2MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSERPASIL-APRESOLINE
Active IngredientHYDRALAZINE HYDROCHLORIDE; RESERPINE



Back to FDA Applications sponsored by NOVARTIS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.